Emerald Mutual Fund Advisers Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
16,440
+182
+1% +$15.5K 0.05% 142
2026
Q1
$1.4M Sell
16,258
-701
-4% -$62.9K 0.07% 136
2025
Q4
$1.48M Buy
16,959
+2,698
+19% +$205K 0.07% 131
2025
Q3
$817K Buy
14,261
+605
+4% +$34.8K 0.04% 151
2025
Q2
$806K Buy
13,656
+180
+1% +$11.6K 0.05% 147
2025
Q1
$986K Buy
+13,476
New +$1.11M 0.07% 132

Other funds holding GMED

Emerald Mutual Fund Advisers Trust's GMED Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Globus Medical (GMED) stake by 1.1% in Q2 2026, buying an estimated $15.5K and bringing the position to 16,440 shares worth $1.3M. The position accounts for 0.05% of the portfolio, ranked #142.

Emerald Mutual Fund Advisers Trust first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.48M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Emerald Mutual Fund Advisers Trust held 16,440 shares of Globus Medical worth $1.3M as of Q2 2026.
  • Emerald Mutual Fund Advisers Trust bought 182 Globus Medical shares in Q2 2026, an estimated $15.5K.
  • Globus Medical made up 0.05% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #142 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • Emerald Mutual Fund Advisers Trust's Globus Medical position peaked at $1.48M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.